Business Description
Founded in 2018 and headquartered in Boston, Massachusetts, PepGen is a medical research company working to bring new treatments to patients with serious nervous system and muscle disorders. Its pipeline centers on a proprietary peptide-based delivery technology designed to improve how therapeutic molecules reach affected tissues. Several of its programs targeting myotonic dystrophy type 1 are currently being evaluated in Phase 2 clinical trials.
